ERBB2 and breast carcinoma: Accumulating evidence including multiple independent studies and meta-analyses have shown the correlation between tumor-infiltrating lymphocytes (TILs) and favorable prognosis in triple-negative breast cancer (TNBC) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [3, 4].